MGS, a healthcare contract development and manufacturing organisation (CDMO), has introduced its newest manufacturing facility in Richfield, Wisconsin.
Axplora has announced a multi-million-euro investment to expand lyophilisation (freeze-drying) capabilities at its Le Mans site, strengthening its ability to deliver reliable, efficient and fast ADC manufacturing for biotech and pharma customers.
HORIBA announces plans to build a new global headquarters on the site of its current head office in Kisshoin, Minami-ku, Kyoto. Construction began in December 2025, and completion is planned for January 2028.
Vetter, a pharmaceutical service provider for the production of injectable drugs, has confirmed its plans to build a production facility in the Saarland region of southwest Germany.
Sharp Services, an expert in pharmaceutical packaging, clinical trial services & sterile manufacturing, has announced it has invested over €20 million in its European packaging facilities in response to strong market demand in the injectables market.
Jubilant Biosys, a wholly owned subsidiary of Jubilant Pharmova, and a CRDMO operating from five sites across India and Europe, announced the opening of a new discovery and preclinical facility at Noida, doubling its overall chemistry capacity.
Symbiosis Pharmaceutical Services (Symbiosis), a sterile fill finish contract manufacturing organisation (CMO), has manufactured their first 10,000 vial batch at the company’s new facility in Stirling, UK.
Almac Group has announced a multi-million-pound investment to expand its facility in Singapore, as the company marks ten years of operations in the country.
AES Cleanroom Technology has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.
